Skip to content
Open Data Finder
Open Government Canada

Guidance Document: Conduct and Analysis of Comparative Bioavailability Studies

Published by Health Canada | Santé Canada

About this dataset

To provide sponsors of new drug submissions with the information necessary to comply with Sections C.08.002(2)(h), C.08.002.1(2)(c)(ii) and C.08.003(3) of the Food and Drug Regulations (Regulations) with respect to comparative bioavailability studies used in support of the safety and efficacy of a drug.

Guidance Document: Conduct and Analysis of Comparative Bioavailability Studies · Open Data Finder